nodes	percent_of_prediction	percent_of_DWPC	metapath
Chloroquine—TNF—psoriasis	0.363	1	CbGaD
Chloroquine—CYP1A1—Clobetasol propionate—psoriasis	0.0724	0.16	CbGbCtD
Chloroquine—CYP1A1—Methoxsalen—psoriasis	0.038	0.0841	CbGbCtD
Chloroquine—CYP2C8—Tazarotene—psoriasis	0.0341	0.0753	CbGbCtD
Chloroquine—CYP3A5—Beclomethasone—psoriasis	0.0329	0.0728	CbGbCtD
Chloroquine—CYP1A1—Cholecalciferol—psoriasis	0.0252	0.0557	CbGbCtD
Chloroquine—CYP2D6—Hydroxyurea—psoriasis	0.0153	0.0338	CbGbCtD
Chloroquine—CYP2C8—Cholecalciferol—psoriasis	0.0145	0.0322	CbGbCtD
Chloroquine—CYP3A5—Mycophenolate mofetil—psoriasis	0.0131	0.029	CbGbCtD
Chloroquine—CYP2C8—Mycophenolate mofetil—psoriasis	0.0126	0.0279	CbGbCtD
Chloroquine—CYP3A4—Calcitriol—psoriasis	0.0114	0.0253	CbGbCtD
Chloroquine—CYP1A1—Dexamethasone—psoriasis	0.0109	0.0241	CbGbCtD
Chloroquine—CYP3A5—Hydrocortisone—psoriasis	0.0105	0.0233	CbGbCtD
Chloroquine—CYP2C8—Hydrocortisone—psoriasis	0.0101	0.0224	CbGbCtD
Chloroquine—CYP3A5—Cyclosporine—psoriasis	0.00994	0.022	CbGbCtD
Chloroquine—CYP2C8—Cyclosporine—psoriasis	0.00956	0.0211	CbGbCtD
Chloroquine—CYP2D6—Cholecalciferol—psoriasis	0.00928	0.0205	CbGbCtD
Chloroquine—CYP3A4—Methoxsalen—psoriasis	0.0089	0.0197	CbGbCtD
Chloroquine—ABCB1—Mycophenolate mofetil—psoriasis	0.00854	0.0189	CbGbCtD
Chloroquine—ABCB1—Betamethasone—psoriasis	0.00732	0.0162	CbGbCtD
Chloroquine—ABCB1—Prednisolone—psoriasis	0.00723	0.016	CbGbCtD
Chloroquine—ABCB1—Hydrocortisone—psoriasis	0.00685	0.0151	CbGbCtD
Chloroquine—ABCB1—Prednisone—psoriasis	0.00682	0.0151	CbGbCtD
Chloroquine—CYP3A5—Dexamethasone—psoriasis	0.00655	0.0145	CbGbCtD
Chloroquine—ABCB1—Cyclosporine—psoriasis	0.00647	0.0143	CbGbCtD
Chloroquine—CYP2C8—Dexamethasone—psoriasis	0.00629	0.0139	CbGbCtD
Chloroquine—CYP2D6—Cyclosporine—psoriasis	0.00609	0.0135	CbGbCtD
Chloroquine—CYP3A4—Cholecalciferol—psoriasis	0.0059	0.013	CbGbCtD
Chloroquine—CYP3A4—Triamcinolone—psoriasis	0.00511	0.0113	CbGbCtD
Chloroquine—CYP3A4—Mycophenolate mofetil—psoriasis	0.00511	0.0113	CbGbCtD
Chloroquine—CYP3A4—Betamethasone—psoriasis	0.00439	0.0097	CbGbCtD
Chloroquine—CYP3A4—Prednisolone—psoriasis	0.00433	0.00957	CbGbCtD
Chloroquine—ABCB1—Dexamethasone—psoriasis	0.00426	0.00942	CbGbCtD
Chloroquine—CYP3A4—Hydrocortisone—psoriasis	0.0041	0.00907	CbGbCtD
Chloroquine—CYP3A4—Prednisone—psoriasis	0.00409	0.00904	CbGbCtD
Chloroquine—CYP2D6—Dexamethasone—psoriasis	0.00401	0.00887	CbGbCtD
Chloroquine—CYP3A4—Cyclosporine—psoriasis	0.00388	0.00857	CbGbCtD
Chloroquine—ABCB1—Methotrexate—psoriasis	0.00342	0.00757	CbGbCtD
Chloroquine—CYP3A4—Dexamethasone—psoriasis	0.00255	0.00564	CbGbCtD
Chloroquine—Vision blurred—Mycophenolic acid—psoriasis	0.000168	0.0015	CcSEcCtD
Chloroquine—Agranulocytosis—Mycophenolate mofetil—psoriasis	0.000168	0.0015	CcSEcCtD
Chloroquine—Nausea—Methoxsalen—psoriasis	0.000166	0.00148	CcSEcCtD
Chloroquine—Hepatitis—Cyclosporine—psoriasis	0.000166	0.00148	CcSEcCtD
Chloroquine—Anorexia—Hydroxyurea—psoriasis	0.000166	0.00148	CcSEcCtD
Chloroquine—Agitation—Mycophenolic acid—psoriasis	0.000164	0.00147	CcSEcCtD
Chloroquine—Hepatitis—Mycophenolate mofetil—psoriasis	0.000162	0.00145	CcSEcCtD
Chloroquine—Hallucination—Mycophenolate mofetil—psoriasis	0.000161	0.00144	CcSEcCtD
Chloroquine—Visual impairment—Cyclosporine—psoriasis	0.00016	0.00143	CcSEcCtD
Chloroquine—Asthenia—Acitretin—psoriasis	0.000159	0.00142	CcSEcCtD
Chloroquine—Vomiting—Calcitriol—psoriasis	0.000158	0.00142	CcSEcCtD
Chloroquine—Rash—Calcitriol—psoriasis	0.000157	0.0014	CcSEcCtD
Chloroquine—Pruritus—Acitretin—psoriasis	0.000157	0.0014	CcSEcCtD
Chloroquine—Pruritus—Fluocinolone Acetonide—psoriasis	0.000156	0.0014	CcSEcCtD
Chloroquine—Headache—Calcitriol—psoriasis	0.000156	0.0014	CcSEcCtD
Chloroquine—Visual impairment—Mycophenolate mofetil—psoriasis	0.000156	0.00139	CcSEcCtD
Chloroquine—Psychotic disorder—Prednisone—psoriasis	0.000155	0.00139	CcSEcCtD
Chloroquine—Tinnitus—Cyclosporine—psoriasis	0.000155	0.00138	CcSEcCtD
Chloroquine—Convulsion—Mycophenolic acid—psoriasis	0.000154	0.00138	CcSEcCtD
Chloroquine—Diarrhoea—Acitretin—psoriasis	0.000151	0.00136	CcSEcCtD
Chloroquine—Anxiety—Mycophenolic acid—psoriasis	0.000151	0.00135	CcSEcCtD
Chloroquine—Decreased appetite—Hydroxyurea—psoriasis	0.000151	0.00135	CcSEcCtD
Chloroquine—Diarrhoea—Fluocinolone Acetonide—psoriasis	0.000151	0.00135	CcSEcCtD
Chloroquine—Photosensitivity—Methotrexate—psoriasis	0.000151	0.00135	CcSEcCtD
Chloroquine—Tinnitus—Mycophenolate mofetil—psoriasis	0.000151	0.00135	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Hydroxyurea—psoriasis	0.00015	0.00134	CcSEcCtD
Chloroquine—Nausea—Calcitriol—psoriasis	0.000148	0.00132	CcSEcCtD
Chloroquine—Confusional state—Mycophenolic acid—psoriasis	0.000147	0.00131	CcSEcCtD
Chloroquine—Hallucination—Hydrocortisone—psoriasis	0.000147	0.00131	CcSEcCtD
Chloroquine—Alopecia—Cyclosporine—psoriasis	0.000146	0.00131	CcSEcCtD
Chloroquine—Visual impairment—Prednisolone—psoriasis	0.000145	0.0013	CcSEcCtD
Chloroquine—Feeling abnormal—Hydroxyurea—psoriasis	0.000143	0.00128	CcSEcCtD
Chloroquine—Alopecia—Mycophenolate mofetil—psoriasis	0.000143	0.00128	CcSEcCtD
Chloroquine—Thrombocytopenia—Mycophenolic acid—psoriasis	0.000142	0.00128	CcSEcCtD
Chloroquine—Vomiting—Acitretin—psoriasis	0.000141	0.00126	CcSEcCtD
Chloroquine—Vomiting—Fluocinolone Acetonide—psoriasis	0.00014	0.00126	CcSEcCtD
Chloroquine—Dermatitis exfoliative—Methotrexate—psoriasis	0.00014	0.00126	CcSEcCtD
Chloroquine—Visual disturbance—Methotrexate—psoriasis	0.00014	0.00125	CcSEcCtD
Chloroquine—Rash—Acitretin—psoriasis	0.00014	0.00125	CcSEcCtD
Chloroquine—Rash—Fluocinolone Acetonide—psoriasis	0.000139	0.00125	CcSEcCtD
Chloroquine—Anorexia—Mycophenolic acid—psoriasis	0.000139	0.00124	CcSEcCtD
Chloroquine—Headache—Acitretin—psoriasis	0.000139	0.00124	CcSEcCtD
Chloroquine—Headache—Fluocinolone Acetonide—psoriasis	0.000138	0.00124	CcSEcCtD
Chloroquine—Anaphylactoid reaction—Methotrexate—psoriasis	0.000137	0.00122	CcSEcCtD
Chloroquine—Hypotension—Mycophenolic acid—psoriasis	0.000136	0.00122	CcSEcCtD
Chloroquine—Vision blurred—Cyclosporine—psoriasis	0.000136	0.00122	CcSEcCtD
Chloroquine—Agitation—Cyclosporine—psoriasis	0.000133	0.00119	CcSEcCtD
Chloroquine—Angioedema—Cyclosporine—psoriasis	0.000132	0.00118	CcSEcCtD
Chloroquine—Insomnia—Mycophenolic acid—psoriasis	0.000132	0.00118	CcSEcCtD
Chloroquine—Nausea—Acitretin—psoriasis	0.000131	0.00118	CcSEcCtD
Chloroquine—Nausea—Fluocinolone Acetonide—psoriasis	0.000131	0.00117	CcSEcCtD
Chloroquine—Agitation—Mycophenolate mofetil—psoriasis	0.000129	0.00116	CcSEcCtD
Chloroquine—Angioedema—Mycophenolate mofetil—psoriasis	0.000129	0.00115	CcSEcCtD
Chloroquine—Neutropenia—Prednisone—psoriasis	0.000128	0.00115	CcSEcCtD
Chloroquine—Decreased appetite—Mycophenolic acid—psoriasis	0.000127	0.00113	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.000126	0.00112	CcSEcCtD
Chloroquine—Hallucination—Betamethasone—psoriasis	0.000125	0.00112	CcSEcCtD
Chloroquine—Hallucination—Dexamethasone—psoriasis	0.000125	0.00112	CcSEcCtD
Chloroquine—Convulsion—Cyclosporine—psoriasis	0.000125	0.00112	CcSEcCtD
Chloroquine—Asthenia—Hydroxyurea—psoriasis	0.000125	0.00112	CcSEcCtD
Chloroquine—Vision blurred—Prednisolone—psoriasis	0.000124	0.00111	CcSEcCtD
Chloroquine—TLR9—MyD88 dependent cascade initiated on endosome—IL6—psoriasis	0.000123	0.00169	CbGpPWpGaD
Chloroquine—TLR9—IRS-related events—IL6—psoriasis	0.000123	0.00169	CbGpPWpGaD
Chloroquine—Anxiety—Cyclosporine—psoriasis	0.000122	0.0011	CcSEcCtD
Chloroquine—TNF—Selenium Micronutrient Network—CRP—psoriasis	0.000122	0.00168	CbGpPWpGaD
Chloroquine—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	0.000122	0.00168	CbGpPWpGaD
Chloroquine—Convulsion—Mycophenolate mofetil—psoriasis	0.000122	0.00109	CcSEcCtD
Chloroquine—TLR9—IRS-related events triggered by IGF1R—IL6—psoriasis	0.000122	0.00167	CbGpPWpGaD
Chloroquine—Visual impairment—Betamethasone—psoriasis	0.000121	0.00109	CcSEcCtD
Chloroquine—Visual impairment—Dexamethasone—psoriasis	0.000121	0.00109	CcSEcCtD
Chloroquine—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	0.00012	0.00165	CbGpPWpGaD
Chloroquine—Angioedema—Prednisolone—psoriasis	0.00012	0.00107	CcSEcCtD
Chloroquine—Feeling abnormal—Mycophenolic acid—psoriasis	0.00012	0.00107	CcSEcCtD
Chloroquine—TNF—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	0.00012	0.00164	CbGpPWpGaD
Chloroquine—TNF—TNF receptor signaling pathway —NFKB1—psoriasis	0.00012	0.00164	CbGpPWpGaD
Chloroquine—Anxiety—Mycophenolate mofetil—psoriasis	0.000119	0.00107	CcSEcCtD
Chloroquine—Toxic epidermal necrolysis—Methotrexate—psoriasis	0.000119	0.00107	CcSEcCtD
Chloroquine—Diarrhoea—Hydroxyurea—psoriasis	0.000119	0.00106	CcSEcCtD
Chloroquine—Confusional state—Cyclosporine—psoriasis	0.000119	0.00106	CcSEcCtD
Chloroquine—TNF—Adipogenesis—SOCS1—psoriasis	0.000119	0.00163	CbGpPWpGaD
Chloroquine—TNF—IL27-mediated signaling events—IL6—psoriasis	0.000119	0.00163	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—HLA-E—psoriasis	0.000118	0.00163	CbGpPWpGaD
Chloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—IL6—psoriasis	0.000118	0.00163	CbGpPWpGaD
Chloroquine—TLR9—IGF1R signaling cascade—IL6—psoriasis	0.000118	0.00163	CbGpPWpGaD
Chloroquine—TLR9—Insulin receptor signalling cascade—IL6—psoriasis	0.000118	0.00163	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—CYP2S1—psoriasis	0.000118	0.00162	CbGpPWpGaD
Chloroquine—Anaphylactic shock—Cyclosporine—psoriasis	0.000118	0.00105	CcSEcCtD
Chloroquine—Angioedema—Hydrocortisone—psoriasis	0.000117	0.00105	CcSEcCtD
Chloroquine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—psoriasis	0.000116	0.0016	CbGpPWpGaD
Chloroquine—TNF—Transcriptional regulation of white adipocyte differentiation—PPARG—psoriasis	0.000116	0.0016	CbGpPWpGaD
Chloroquine—Confusional state—Mycophenolate mofetil—psoriasis	0.000116	0.00104	CcSEcCtD
Chloroquine—TNF—Apoptosis—NFKBIA—psoriasis	0.000116	0.00159	CbGpPWpGaD
Chloroquine—TNF—Ceramide signaling pathway—NFKB1—psoriasis	0.000116	0.00159	CbGpPWpGaD
Chloroquine—Thrombocytopenia—Cyclosporine—psoriasis	0.000115	0.00103	CcSEcCtD
Chloroquine—Abdominal pain—Mycophenolic acid—psoriasis	0.000115	0.00103	CcSEcCtD
Chloroquine—CYP1A1—PPARA activates gene expression—CARM1—psoriasis	0.000115	0.00158	CbGpPWpGaD
Chloroquine—TNF—Cytokines and Inflammatory Response—IL6—psoriasis	0.000115	0.00158	CbGpPWpGaD
Chloroquine—Anaphylactic shock—Mycophenolate mofetil—psoriasis	0.000115	0.00103	CcSEcCtD
Chloroquine—Convulsion—Prednisolone—psoriasis	0.000114	0.00102	CcSEcCtD
Chloroquine—Eosinophilia—Methotrexate—psoriasis	0.000113	0.00101	CcSEcCtD
Chloroquine—TLR9—Signaling Pathways—TAGAP—psoriasis	0.000113	0.00155	CbGpPWpGaD
Chloroquine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	0.000113	0.00155	CbGpPWpGaD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—SOCS1—psoriasis	0.000113	0.00155	CbGpPWpGaD
Chloroquine—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.000112	0.00101	CcSEcCtD
Chloroquine—TNF—Selenium Micronutrient Network—ICAM1—psoriasis	0.000112	0.00155	CbGpPWpGaD
Chloroquine—Anorexia—Cyclosporine—psoriasis	0.000112	0.001	CcSEcCtD
Chloroquine—TNF—Spinal Cord Injury—IL4—psoriasis	0.000112	0.00154	CbGpPWpGaD
Chloroquine—TNF—Angiopoietin receptor Tie2-mediated signaling—NFKB1—psoriasis	0.000112	0.00154	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—HLA-C—psoriasis	0.000112	0.00154	CbGpPWpGaD
Chloroquine—Alopecia—Dexamethasone—psoriasis	0.000111	0.000996	CcSEcCtD
Chloroquine—Alopecia—Betamethasone—psoriasis	0.000111	0.000996	CcSEcCtD
Chloroquine—ABCB1—Allograft Rejection—IL13—psoriasis	0.000111	0.00153	CbGpPWpGaD
Chloroquine—Convulsion—Hydrocortisone—psoriasis	0.000111	0.000995	CcSEcCtD
Chloroquine—Vomiting—Hydroxyurea—psoriasis	0.00011	0.000989	CcSEcCtD
Chloroquine—Angioedema—Triamcinolone—psoriasis	0.00011	0.000988	CcSEcCtD
Chloroquine—TNF—Vitamin B12 Metabolism—NFKB1—psoriasis	0.00011	0.00151	CbGpPWpGaD
Chloroquine—Rash—Hydroxyurea—psoriasis	0.00011	0.000981	CcSEcCtD
Chloroquine—Anorexia—Mycophenolate mofetil—psoriasis	0.000109	0.00098	CcSEcCtD
Chloroquine—TNF—TGF-beta Receptor Signaling—JUN—psoriasis	0.000109	0.0015	CbGpPWpGaD
Chloroquine—TLR9—Toll-like Receptor Signaling Pathway—IL6—psoriasis	0.000109	0.0015	CbGpPWpGaD
Chloroquine—Hallucination—Prednisone—psoriasis	0.000109	0.000976	CcSEcCtD
Chloroquine—Headache—Hydroxyurea—psoriasis	0.000109	0.000975	CcSEcCtD
Chloroquine—Anxiety—Hydrocortisone—psoriasis	0.000109	0.000974	CcSEcCtD
Chloroquine—Pancytopenia—Methotrexate—psoriasis	0.000109	0.000973	CcSEcCtD
Chloroquine—TNF—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	0.000109	0.00149	CbGpPWpGaD
Chloroquine—TNF—Folate Metabolism—IFNG—psoriasis	0.000108	0.00148	CbGpPWpGaD
Chloroquine—TNF—Downstream signaling in naïve CD8+ T cells—IFNG—psoriasis	0.000108	0.00148	CbGpPWpGaD
Chloroquine—TNF—TNF alpha Signaling Pathway—NFKBIA—psoriasis	0.000108	0.00148	CbGpPWpGaD
Chloroquine—Hypotension—Mycophenolate mofetil—psoriasis	0.000107	0.000961	CcSEcCtD
Chloroquine—Anaphylactic shock—Prednisolone—psoriasis	0.000107	0.000959	CcSEcCtD
Chloroquine—Neutropenia—Methotrexate—psoriasis	0.000107	0.000958	CcSEcCtD
Chloroquine—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—NFKB1—psoriasis	0.000107	0.00147	CbGpPWpGaD
Chloroquine—Insomnia—Cyclosporine—psoriasis	0.000106	0.000953	CcSEcCtD
Chloroquine—TLR9—Regulation of toll-like receptor signaling pathway—TNF—psoriasis	0.000105	0.00145	CbGpPWpGaD
Chloroquine—TNF—TGF-beta Receptor Signaling—NFKB1—psoriasis	0.000105	0.00145	CbGpPWpGaD
Chloroquine—Anaphylactic shock—Hydrocortisone—psoriasis	0.000105	0.000937	CcSEcCtD
Chloroquine—Convulsion—Triamcinolone—psoriasis	0.000105	0.000936	CcSEcCtD
Chloroquine—Photosensitivity reaction—Methotrexate—psoriasis	0.000104	0.000935	CcSEcCtD
Chloroquine—Asthenia—Mycophenolic acid—psoriasis	0.000104	0.000935	CcSEcCtD
Chloroquine—Insomnia—Mycophenolate mofetil—psoriasis	0.000104	0.00093	CcSEcCtD
Chloroquine—TNF—Cardiac Hypertrophic Response—NFKB1—psoriasis	0.000104	0.00143	CbGpPWpGaD
Chloroquine—Nausea—Hydroxyurea—psoriasis	0.000103	0.000924	CcSEcCtD
Chloroquine—Pruritus—Mycophenolic acid—psoriasis	0.000103	0.000922	CcSEcCtD
Chloroquine—Decreased appetite—Cyclosporine—psoriasis	0.000102	0.000916	CcSEcCtD
Chloroquine—ABCB1—Allograft Rejection—IL17A—psoriasis	0.000102	0.00141	CbGpPWpGaD
Chloroquine—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000102	0.00091	CcSEcCtD
Chloroquine—Stevens-Johnson syndrome—Methotrexate—psoriasis	0.000101	0.000906	CcSEcCtD
Chloroquine—TNF—amb2 Integrin signaling—IL6—psoriasis	0.0001	0.00138	CbGpPWpGaD
Chloroquine—Angioedema—Betamethasone—psoriasis	0.0001	0.000896	CcSEcCtD
Chloroquine—Angioedema—Dexamethasone—psoriasis	0.0001	0.000896	CcSEcCtD
Chloroquine—Decreased appetite—Mycophenolate mofetil—psoriasis	9.98e-05	0.000894	CcSEcCtD
Chloroquine—Anorexia—Hydrocortisone—psoriasis	9.97e-05	0.000893	CcSEcCtD
Chloroquine—Diarrhoea—Mycophenolic acid—psoriasis	9.96e-05	0.000892	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	9.92e-05	0.000888	CcSEcCtD
Chloroquine—TNF—Toll-like Receptor Signaling Pathway—NFKBIA—psoriasis	9.91e-05	0.00136	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—SOCS1—psoriasis	9.9e-05	0.00136	CbGpPWpGaD
Chloroquine—Anaphylactic shock—Triamcinolone—psoriasis	9.85e-05	0.000882	CcSEcCtD
Chloroquine—TLR9—Signaling by Insulin receptor—IL6—psoriasis	9.84e-05	0.00135	CbGpPWpGaD
Chloroquine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	9.78e-05	0.00134	CbGpPWpGaD
Chloroquine—Hypotension—Hydrocortisone—psoriasis	9.78e-05	0.000875	CcSEcCtD
Chloroquine—Feeling abnormal—Cyclosporine—psoriasis	9.7e-05	0.000869	CcSEcCtD
Chloroquine—Insomnia—Prednisolone—psoriasis	9.69e-05	0.000868	CcSEcCtD
Chloroquine—Alopecia—Prednisone—psoriasis	9.68e-05	0.000867	CcSEcCtD
Chloroquine—TLR9—Immune System—ITGAL—psoriasis	9.66e-05	0.00133	CbGpPWpGaD
Chloroquine—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—psoriasis	9.56e-05	0.00131	CbGpPWpGaD
Chloroquine—Agranulocytosis—Methotrexate—psoriasis	9.52e-05	0.000852	CcSEcCtD
Chloroquine—ABCB1—Allograft Rejection—IL12B—psoriasis	9.51e-05	0.00131	CbGpPWpGaD
Chloroquine—CYP1A1—Melatonin metabolism and effects—NFKB1—psoriasis	9.5e-05	0.00131	CbGpPWpGaD
Chloroquine—Convulsion—Dexamethasone—psoriasis	9.49e-05	0.00085	CcSEcCtD
Chloroquine—Convulsion—Betamethasone—psoriasis	9.49e-05	0.00085	CcSEcCtD
Chloroquine—TNF—Spinal Cord Injury—LEP—psoriasis	9.47e-05	0.0013	CbGpPWpGaD
Chloroquine—Feeling abnormal—Mycophenolate mofetil—psoriasis	9.46e-05	0.000847	CcSEcCtD
Chloroquine—Insomnia—Hydrocortisone—psoriasis	9.46e-05	0.000847	CcSEcCtD
Chloroquine—TNF—TGF-beta Receptor Signaling—STAT3—psoriasis	9.45e-05	0.0013	CbGpPWpGaD
Chloroquine—Urticaria—Cyclosporine—psoriasis	9.35e-05	0.000837	CcSEcCtD
Chloroquine—TNF—Allograft Rejection—IFNG—psoriasis	9.33e-05	0.00128	CbGpPWpGaD
Chloroquine—TNF—Downstream signaling in naïve CD8+ T cells—JUN—psoriasis	9.31e-05	0.00128	CbGpPWpGaD
Chloroquine—Abdominal pain—Cyclosporine—psoriasis	9.31e-05	0.000833	CcSEcCtD
Chloroquine—Anxiety—Dexamethasone—psoriasis	9.29e-05	0.000832	CcSEcCtD
Chloroquine—Anxiety—Betamethasone—psoriasis	9.29e-05	0.000832	CcSEcCtD
Chloroquine—ABCB1—Allograft Rejection—HLA-E—psoriasis	9.28e-05	0.00128	CbGpPWpGaD
Chloroquine—Vomiting—Mycophenolic acid—psoriasis	9.25e-05	0.000828	CcSEcCtD
Chloroquine—CYP1A1—Oxidative Stress—NFKB1—psoriasis	9.24e-05	0.00127	CbGpPWpGaD
Chloroquine—TNF—SIDS Susceptibility Pathways—IL10—psoriasis	9.2e-05	0.00127	CbGpPWpGaD
Chloroquine—Rash—Mycophenolic acid—psoriasis	9.18e-05	0.000822	CcSEcCtD
Chloroquine—Hepatitis—Methotrexate—psoriasis	9.16e-05	0.00082	CcSEcCtD
Chloroquine—Urticaria—Mycophenolate mofetil—psoriasis	9.12e-05	0.000817	CcSEcCtD
Chloroquine—Headache—Mycophenolic acid—psoriasis	9.12e-05	0.000816	CcSEcCtD
Chloroquine—Decreased appetite—Hydrocortisone—psoriasis	9.1e-05	0.000814	CcSEcCtD
Chloroquine—Abdominal pain—Mycophenolate mofetil—psoriasis	9.08e-05	0.000813	CcSEcCtD
Chloroquine—TLR9—Immune System—REL—psoriasis	9.04e-05	0.00124	CbGpPWpGaD
Chloroquine—Gastrointestinal disorder—Hydrocortisone—psoriasis	9.03e-05	0.000809	CcSEcCtD
Chloroquine—Vision blurred—Prednisone—psoriasis	8.99e-05	0.000805	CcSEcCtD
Chloroquine—TNF—Folate Metabolism—NFKB1—psoriasis	8.96e-05	0.00123	CbGpPWpGaD
Chloroquine—Anaphylactic shock—Betamethasone—psoriasis	8.94e-05	0.0008	CcSEcCtD
Chloroquine—Anaphylactic shock—Dexamethasone—psoriasis	8.94e-05	0.0008	CcSEcCtD
Chloroquine—TNF—IL23-mediated signaling events—IL6—psoriasis	8.94e-05	0.00123	CbGpPWpGaD
Chloroquine—Insomnia—Triamcinolone—psoriasis	8.91e-05	0.000798	CcSEcCtD
Chloroquine—TNF—Spinal Cord Injury—ICAM1—psoriasis	8.89e-05	0.00122	CbGpPWpGaD
Chloroquine—Feeling abnormal—Prednisolone—psoriasis	8.83e-05	0.00079	CcSEcCtD
Chloroquine—Visual impairment—Methotrexate—psoriasis	8.83e-05	0.00079	CcSEcCtD
Chloroquine—TNF—Spinal Cord Injury—NOS2—psoriasis	8.82e-05	0.00121	CbGpPWpGaD
Chloroquine—TLR9—Immune System—IFIH1—psoriasis	8.77e-05	0.00121	CbGpPWpGaD
Chloroquine—Agitation—Prednisone—psoriasis	8.77e-05	0.000785	CcSEcCtD
Chloroquine—TNF—Adipogenesis—LEP—psoriasis	8.76e-05	0.0012	CbGpPWpGaD
Chloroquine—Thrombocytopenia—Dexamethasone—psoriasis	8.75e-05	0.000784	CcSEcCtD
Chloroquine—Thrombocytopenia—Betamethasone—psoriasis	8.75e-05	0.000784	CcSEcCtD
Chloroquine—Angioedema—Prednisone—psoriasis	8.72e-05	0.00078	CcSEcCtD
Chloroquine—TNF—Allograft Rejection—CXCL8—psoriasis	8.67e-05	0.00119	CbGpPWpGaD
Chloroquine—Erythema multiforme—Methotrexate—psoriasis	8.66e-05	0.000775	CcSEcCtD
Chloroquine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	8.64e-05	0.00119	CbGpPWpGaD
Chloroquine—Nausea—Mycophenolic acid—psoriasis	8.64e-05	0.000774	CcSEcCtD
Chloroquine—Feeling abnormal—Hydrocortisone—psoriasis	8.62e-05	0.000772	CcSEcCtD
Chloroquine—TNF—Selenium Micronutrient Network—IFNG—psoriasis	8.55e-05	0.00118	CbGpPWpGaD
Chloroquine—TNF—Signaling events mediated by HDAC Class I—NFKB1—psoriasis	8.55e-05	0.00118	CbGpPWpGaD
Chloroquine—Tinnitus—Methotrexate—psoriasis	8.54e-05	0.000764	CcSEcCtD
Chloroquine—Anorexia—Dexamethasone—psoriasis	8.52e-05	0.000763	CcSEcCtD
Chloroquine—Anorexia—Betamethasone—psoriasis	8.52e-05	0.000763	CcSEcCtD
Chloroquine—TLR9—Regulation of toll-like receptor signaling pathway—IL6—psoriasis	8.51e-05	0.00117	CbGpPWpGaD
Chloroquine—Urticaria—Prednisolone—psoriasis	8.51e-05	0.000762	CcSEcCtD
Chloroquine—Asthenia—Cyclosporine—psoriasis	8.45e-05	0.000756	CcSEcCtD
Chloroquine—TLR9—Innate Immune System—HLA-B—psoriasis	8.44e-05	0.00116	CbGpPWpGaD
Chloroquine—TLR9—Toll-Like Receptors Cascades—IL6—psoriasis	8.42e-05	0.00116	CbGpPWpGaD
Chloroquine—Hypotension—Betamethasone—psoriasis	8.35e-05	0.000748	CcSEcCtD
Chloroquine—Hypotension—Dexamethasone—psoriasis	8.35e-05	0.000748	CcSEcCtD
Chloroquine—Pruritus—Cyclosporine—psoriasis	8.33e-05	0.000746	CcSEcCtD
Chloroquine—TLR9—Immune System—HLA-C—psoriasis	8.32e-05	0.00114	CbGpPWpGaD
Chloroquine—Urticaria—Hydrocortisone—psoriasis	8.31e-05	0.000744	CcSEcCtD
Chloroquine—Abdominal pain—Hydrocortisone—psoriasis	8.27e-05	0.000741	CcSEcCtD
Chloroquine—Convulsion—Prednisone—psoriasis	8.26e-05	0.00074	CcSEcCtD
Chloroquine—Asthenia—Mycophenolate mofetil—psoriasis	8.24e-05	0.000738	CcSEcCtD
Chloroquine—TLR9—Immune System—TNFAIP3—psoriasis	8.21e-05	0.00113	CbGpPWpGaD
Chloroquine—Pruritus—Mycophenolate mofetil—psoriasis	8.13e-05	0.000728	CcSEcCtD
Chloroquine—Feeling abnormal—Triamcinolone—psoriasis	8.12e-05	0.000727	CcSEcCtD
Chloroquine—CYP3A4—Biological oxidations—CYP2S1—psoriasis	8.1e-05	0.00111	CbGpPWpGaD
Chloroquine—Anxiety—Prednisone—psoriasis	8.09e-05	0.000725	CcSEcCtD
Chloroquine—Alopecia—Methotrexate—psoriasis	8.09e-05	0.000725	CcSEcCtD
Chloroquine—Insomnia—Betamethasone—psoriasis	8.09e-05	0.000724	CcSEcCtD
Chloroquine—Insomnia—Dexamethasone—psoriasis	8.09e-05	0.000724	CcSEcCtD
Chloroquine—TNF—TWEAK Signaling Pathway—IL6—psoriasis	8.07e-05	0.00111	CbGpPWpGaD
Chloroquine—Diarrhoea—Cyclosporine—psoriasis	8.06e-05	0.000721	CcSEcCtD
Chloroquine—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	7.99e-05	0.0011	CbGpPWpGaD
Chloroquine—TNF—Transcriptional regulation of white adipocyte differentiation—NFKB1—psoriasis	7.92e-05	0.00109	CbGpPWpGaD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	7.89e-05	0.00108	CbGpPWpGaD
Chloroquine—Diarrhoea—Mycophenolate mofetil—psoriasis	7.86e-05	0.000704	CcSEcCtD
Chloroquine—Urticaria—Triamcinolone—psoriasis	7.83e-05	0.000701	CcSEcCtD
Chloroquine—Anaphylactic shock—Prednisone—psoriasis	7.79e-05	0.000697	CcSEcCtD
Chloroquine—Decreased appetite—Betamethasone—psoriasis	7.77e-05	0.000696	CcSEcCtD
Chloroquine—Decreased appetite—Dexamethasone—psoriasis	7.77e-05	0.000696	CcSEcCtD
Chloroquine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	7.76e-05	0.00107	CbGpPWpGaD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—NFKBIA—psoriasis	7.74e-05	0.00106	CbGpPWpGaD
Chloroquine—Gastrointestinal disorder—Betamethasone—psoriasis	7.72e-05	0.000691	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Dexamethasone—psoriasis	7.72e-05	0.000691	CcSEcCtD
Chloroquine—TNF—Signaling events mediated by HDAC Class I—STAT3—psoriasis	7.68e-05	0.00106	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	7.68e-05	0.00106	CbGpPWpGaD
Chloroquine—TNF—Apoptosis—JUN—psoriasis	7.68e-05	0.00106	CbGpPWpGaD
Chloroquine—TNF—Adipogenesis—PPARG—psoriasis	7.63e-05	0.00105	CbGpPWpGaD
Chloroquine—Vision blurred—Methotrexate—psoriasis	7.51e-05	0.000673	CcSEcCtD
Chloroquine—Asthenia—Hydrocortisone—psoriasis	7.51e-05	0.000672	CcSEcCtD
Chloroquine—Vomiting—Cyclosporine—psoriasis	7.49e-05	0.00067	CcSEcCtD
Chloroquine—TLR9—Innate Immune System—CRP—psoriasis	7.46e-05	0.00103	CbGpPWpGaD
Chloroquine—Rash—Cyclosporine—psoriasis	7.42e-05	0.000665	CcSEcCtD
Chloroquine—Anorexia—Prednisone—psoriasis	7.42e-05	0.000664	CcSEcCtD
Chloroquine—Pruritus—Hydrocortisone—psoriasis	7.4e-05	0.000663	CcSEcCtD
Chloroquine—TNF—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—psoriasis	7.39e-05	0.00102	CbGpPWpGaD
Chloroquine—TNF—Apoptosis—NFKB1—psoriasis	7.39e-05	0.00102	CbGpPWpGaD
Chloroquine—Headache—Cyclosporine—psoriasis	7.38e-05	0.00066	CcSEcCtD
Chloroquine—Feeling abnormal—Betamethasone—psoriasis	7.37e-05	0.00066	CcSEcCtD
Chloroquine—Feeling abnormal—Dexamethasone—psoriasis	7.37e-05	0.00066	CcSEcCtD
Chloroquine—Vomiting—Mycophenolate mofetil—psoriasis	7.3e-05	0.000654	CcSEcCtD
Chloroquine—Rash—Mycophenolate mofetil—psoriasis	7.24e-05	0.000648	CcSEcCtD
Chloroquine—Headache—Mycophenolate mofetil—psoriasis	7.19e-05	0.000644	CcSEcCtD
Chloroquine—Diarrhoea—Hydrocortisone—psoriasis	7.16e-05	0.000641	CcSEcCtD
Chloroquine—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	7.15e-05	0.000983	CbGpPWpGaD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	7.14e-05	0.000982	CbGpPWpGaD
Chloroquine—TNF—TNF alpha Signaling Pathway—JUN—psoriasis	7.14e-05	0.000981	CbGpPWpGaD
Chloroquine—TNF—Selenium Micronutrient Network—NFKB1—psoriasis	7.12e-05	0.000979	CbGpPWpGaD
Chloroquine—Urticaria—Dexamethasone—psoriasis	7.1e-05	0.000636	CcSEcCtD
Chloroquine—Urticaria—Betamethasone—psoriasis	7.1e-05	0.000636	CcSEcCtD
Chloroquine—Asthenia—Triamcinolone—psoriasis	7.07e-05	0.000633	CcSEcCtD
Chloroquine—TNF—Toll-like Receptor Signaling Pathway—CXCL8—psoriasis	7.07e-05	0.000972	CbGpPWpGaD
Chloroquine—Abdominal pain—Dexamethasone—psoriasis	7.07e-05	0.000633	CcSEcCtD
Chloroquine—Abdominal pain—Betamethasone—psoriasis	7.07e-05	0.000633	CcSEcCtD
Chloroquine—TNF—Allograft Rejection—VEGFA—psoriasis	7.04e-05	0.000968	CbGpPWpGaD
Chloroquine—Insomnia—Prednisone—psoriasis	7.04e-05	0.00063	CcSEcCtD
Chloroquine—Nausea—Cyclosporine—psoriasis	6.99e-05	0.000626	CcSEcCtD
Chloroquine—CYP3A4—Tryptophan metabolism—CAT—psoriasis	6.99e-05	0.000961	CbGpPWpGaD
Chloroquine—Pruritus—Triamcinolone—psoriasis	6.97e-05	0.000624	CcSEcCtD
Chloroquine—ABCB1—Allograft Rejection—IL10—psoriasis	6.95e-05	0.000956	CbGpPWpGaD
Chloroquine—TNF—Vitamin B12 Metabolism—IL6—psoriasis	6.91e-05	0.000951	CbGpPWpGaD
Chloroquine—Convulsion—Methotrexate—psoriasis	6.91e-05	0.000618	CcSEcCtD
Chloroquine—TLR9—Immune System—HLA-E—psoriasis	6.9e-05	0.000949	CbGpPWpGaD
Chloroquine—TNF—TNF alpha Signaling Pathway—NFKB1—psoriasis	6.87e-05	0.000945	CbGpPWpGaD
Chloroquine—Nausea—Mycophenolate mofetil—psoriasis	6.82e-05	0.000611	CcSEcCtD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	6.82e-05	0.000938	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—NFKBIA—psoriasis	6.81e-05	0.000936	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CCL20—psoriasis	6.77e-05	0.000931	CbGpPWpGaD
Chloroquine—Decreased appetite—Prednisone—psoriasis	6.77e-05	0.000606	CcSEcCtD
Chloroquine—TNF—Spinal Cord Injury—IFNG—psoriasis	6.77e-05	0.00093	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—IL4—psoriasis	6.76e-05	0.00093	CbGpPWpGaD
Chloroquine—Rash—Prednisolone—psoriasis	6.75e-05	0.000605	CcSEcCtD
Chloroquine—Headache—Prednisolone—psoriasis	6.71e-05	0.000601	CcSEcCtD
Chloroquine—Vomiting—Hydrocortisone—psoriasis	6.65e-05	0.000596	CcSEcCtD
Chloroquine—TNF—MicroRNAs in cardiomyocyte hypertrophy—STAT3—psoriasis	6.64e-05	0.000913	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—HLA-B—psoriasis	6.61e-05	0.000909	CbGpPWpGaD
Chloroquine—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	6.61e-05	0.000908	CbGpPWpGaD
Chloroquine—Rash—Hydrocortisone—psoriasis	6.6e-05	0.000591	CcSEcCtD
Chloroquine—TNF—Toll-like Receptor Signaling Pathway—JUN—psoriasis	6.57e-05	0.000904	CbGpPWpGaD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	6.57e-05	0.000903	CbGpPWpGaD
Chloroquine—Confusional state—Methotrexate—psoriasis	6.56e-05	0.000587	CcSEcCtD
Chloroquine—Headache—Hydrocortisone—psoriasis	6.55e-05	0.000587	CcSEcCtD
Chloroquine—Anaphylactic shock—Methotrexate—psoriasis	6.51e-05	0.000583	CcSEcCtD
Chloroquine—Feeling abnormal—Prednisone—psoriasis	6.42e-05	0.000574	CcSEcCtD
Chloroquine—Asthenia—Dexamethasone—psoriasis	6.41e-05	0.000574	CcSEcCtD
Chloroquine—Asthenia—Betamethasone—psoriasis	6.41e-05	0.000574	CcSEcCtD
Chloroquine—Thrombocytopenia—Methotrexate—psoriasis	6.37e-05	0.00057	CcSEcCtD
Chloroquine—Nausea—Prednisolone—psoriasis	6.36e-05	0.00057	CcSEcCtD
Chloroquine—TNF—Toll-like Receptor Signaling Pathway—NFKB1—psoriasis	6.33e-05	0.00087	CbGpPWpGaD
Chloroquine—Pruritus—Dexamethasone—psoriasis	6.32e-05	0.000566	CcSEcCtD
Chloroquine—Pruritus—Betamethasone—psoriasis	6.32e-05	0.000566	CcSEcCtD
Chloroquine—TNF—Developmental Biology—CARM1—psoriasis	6.3e-05	0.000866	CbGpPWpGaD
Chloroquine—TNF—Spinal Cord Injury—CXCL8—psoriasis	6.29e-05	0.000865	CbGpPWpGaD
Chloroquine—Vomiting—Triamcinolone—psoriasis	6.26e-05	0.000561	CcSEcCtD
Chloroquine—Nausea—Hydrocortisone—psoriasis	6.22e-05	0.000556	CcSEcCtD
Chloroquine—Rash—Triamcinolone—psoriasis	6.21e-05	0.000556	CcSEcCtD
Chloroquine—Anorexia—Methotrexate—psoriasis	6.2e-05	0.000555	CcSEcCtD
Chloroquine—Urticaria—Prednisone—psoriasis	6.18e-05	0.000554	CcSEcCtD
Chloroquine—Headache—Triamcinolone—psoriasis	6.17e-05	0.000553	CcSEcCtD
Chloroquine—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	6.16e-05	0.000846	CbGpPWpGaD
Chloroquine—Abdominal pain—Prednisone—psoriasis	6.15e-05	0.000551	CcSEcCtD
Chloroquine—TNF—Folate Metabolism—TP53—psoriasis	6.14e-05	0.000845	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—HLA-A—psoriasis	6.13e-05	0.000843	CbGpPWpGaD
Chloroquine—Diarrhoea—Betamethasone—psoriasis	6.12e-05	0.000548	CcSEcCtD
Chloroquine—Diarrhoea—Dexamethasone—psoriasis	6.12e-05	0.000548	CcSEcCtD
Chloroquine—Hypotension—Methotrexate—psoriasis	6.08e-05	0.000544	CcSEcCtD
Chloroquine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	6.03e-05	0.000829	CbGpPWpGaD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	6e-05	0.000825	CbGpPWpGaD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	5.96e-05	0.000819	CbGpPWpGaD
Chloroquine—Insomnia—Methotrexate—psoriasis	5.88e-05	0.000527	CcSEcCtD
Chloroquine—Nausea—Triamcinolone—psoriasis	5.85e-05	0.000524	CcSEcCtD
Chloroquine—GSTA2—Metabolism—CARM1—psoriasis	5.77e-05	0.000793	CbGpPWpGaD
Chloroquine—TLR9—Immune System—SOCS1—psoriasis	5.76e-05	0.000793	CbGpPWpGaD
Chloroquine—Vomiting—Betamethasone—psoriasis	5.68e-05	0.000509	CcSEcCtD
Chloroquine—Vomiting—Dexamethasone—psoriasis	5.68e-05	0.000509	CcSEcCtD
Chloroquine—Decreased appetite—Methotrexate—psoriasis	5.66e-05	0.000506	CcSEcCtD
Chloroquine—Rash—Betamethasone—psoriasis	5.64e-05	0.000505	CcSEcCtD
Chloroquine—Rash—Dexamethasone—psoriasis	5.64e-05	0.000505	CcSEcCtD
Chloroquine—TNF—Folate Metabolism—IL6—psoriasis	5.62e-05	0.000773	CbGpPWpGaD
Chloroquine—Gastrointestinal disorder—Methotrexate—psoriasis	5.62e-05	0.000503	CcSEcCtD
Chloroquine—Headache—Dexamethasone—psoriasis	5.6e-05	0.000501	CcSEcCtD
Chloroquine—Headache—Betamethasone—psoriasis	5.6e-05	0.000501	CcSEcCtD
Chloroquine—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	5.6e-05	0.00077	CbGpPWpGaD
Chloroquine—Asthenia—Prednisone—psoriasis	5.59e-05	0.0005	CcSEcCtD
Chloroquine—TLR9—Innate Immune System—TYK2—psoriasis	5.57e-05	0.000766	CbGpPWpGaD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—CXCL8—psoriasis	5.52e-05	0.000759	CbGpPWpGaD
Chloroquine—Pruritus—Prednisone—psoriasis	5.51e-05	0.000493	CcSEcCtD
Chloroquine—Feeling abnormal—Methotrexate—psoriasis	5.36e-05	0.00048	CcSEcCtD
Chloroquine—Diarrhoea—Prednisone—psoriasis	5.33e-05	0.000477	CcSEcCtD
Chloroquine—TNF—Alzheimers Disease—TP53—psoriasis	5.32e-05	0.000732	CbGpPWpGaD
Chloroquine—Nausea—Betamethasone—psoriasis	5.31e-05	0.000475	CcSEcCtD
Chloroquine—Nausea—Dexamethasone—psoriasis	5.31e-05	0.000475	CcSEcCtD
Chloroquine—Urticaria—Methotrexate—psoriasis	5.17e-05	0.000463	CcSEcCtD
Chloroquine—Abdominal pain—Methotrexate—psoriasis	5.14e-05	0.00046	CcSEcCtD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—JUN—psoriasis	5.13e-05	0.000705	CbGpPWpGaD
Chloroquine—TLR9—Immune System—CD8A—psoriasis	5.11e-05	0.000703	CbGpPWpGaD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	5.11e-05	0.000702	CbGpPWpGaD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—psoriasis	5.11e-05	0.000702	CbGpPWpGaD
Chloroquine—TNF—Apoptosis—TP53—psoriasis	5.07e-05	0.000697	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—CD4—psoriasis	5.04e-05	0.000693	CbGpPWpGaD
Chloroquine—TNF—SIDS Susceptibility Pathways—CXCL8—psoriasis	5.03e-05	0.000692	CbGpPWpGaD
Chloroquine—Vomiting—Prednisone—psoriasis	4.95e-05	0.000443	CcSEcCtD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—NFKB1—psoriasis	4.94e-05	0.000679	CbGpPWpGaD
Chloroquine—TLR9—Immune System—HLA-B—psoriasis	4.92e-05	0.000676	CbGpPWpGaD
Chloroquine—Rash—Prednisone—psoriasis	4.91e-05	0.000439	CcSEcCtD
Chloroquine—Headache—Prednisone—psoriasis	4.88e-05	0.000437	CcSEcCtD
Chloroquine—CYP1A1—PPARA activates gene expression—PPARG—psoriasis	4.79e-05	0.000658	CbGpPWpGaD
Chloroquine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	4.69e-05	0.000644	CbGpPWpGaD
Chloroquine—TNF—Adipogenesis—STAT3—psoriasis	4.68e-05	0.000644	CbGpPWpGaD
Chloroquine—TNF—SIDS Susceptibility Pathways—JUN—psoriasis	4.68e-05	0.000643	CbGpPWpGaD
Chloroquine—Asthenia—Methotrexate—psoriasis	4.67e-05	0.000418	CcSEcCtD
Chloroquine—Nausea—Prednisone—psoriasis	4.62e-05	0.000414	CcSEcCtD
Chloroquine—Pruritus—Methotrexate—psoriasis	4.6e-05	0.000412	CcSEcCtD
Chloroquine—TLR9—Immune System—HLA-A—psoriasis	4.56e-05	0.000626	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—JUN—psoriasis	4.51e-05	0.00062	CbGpPWpGaD
Chloroquine—TNF—SIDS Susceptibility Pathways—NFKB1—psoriasis	4.5e-05	0.000619	CbGpPWpGaD
Chloroquine—TNF—Selenium Micronutrient Network—IL6—psoriasis	4.47e-05	0.000614	CbGpPWpGaD
Chloroquine—Diarrhoea—Methotrexate—psoriasis	4.45e-05	0.000399	CcSEcCtD
Chloroquine—TNF—MAPK Signaling Pathway—JUN—psoriasis	4.41e-05	0.000606	CbGpPWpGaD
Chloroquine—TLR9—Immune System—CRP—psoriasis	4.35e-05	0.000598	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—NFKB1—psoriasis	4.34e-05	0.000597	CbGpPWpGaD
Chloroquine—TNF—TNF alpha Signaling Pathway—IL6—psoriasis	4.31e-05	0.000593	CbGpPWpGaD
Chloroquine—TNF—MAPK Signaling Pathway—NFKB1—psoriasis	4.24e-05	0.000583	CbGpPWpGaD
Chloroquine—TLR9—Immune System—HLA-DRB1—psoriasis	4.16e-05	0.000572	CbGpPWpGaD
Chloroquine—Vomiting—Methotrexate—psoriasis	4.14e-05	0.00037	CcSEcCtD
Chloroquine—Rash—Methotrexate—psoriasis	4.1e-05	0.000367	CcSEcCtD
Chloroquine—ABCB1—Allograft Rejection—IFNG—psoriasis	4.09e-05	0.000562	CbGpPWpGaD
Chloroquine—TNF—SIDS Susceptibility Pathways—VEGFA—psoriasis	4.09e-05	0.000562	CbGpPWpGaD
Chloroquine—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	4.08e-05	0.000561	CbGpPWpGaD
Chloroquine—Headache—Methotrexate—psoriasis	4.08e-05	0.000365	CcSEcCtD
Chloroquine—TLR9—Immune System—ICAM1—psoriasis	4e-05	0.000549	CbGpPWpGaD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	3.98e-05	0.000547	CbGpPWpGaD
Chloroquine—TNF—Toll-like Receptor Signaling Pathway—IL6—psoriasis	3.97e-05	0.000546	CbGpPWpGaD
Chloroquine—TLR9—Immune System—NFKBIA—psoriasis	3.96e-05	0.000545	CbGpPWpGaD
Chloroquine—Nausea—Methotrexate—psoriasis	3.86e-05	0.000346	CcSEcCtD
Chloroquine—TNF—Spinal Cord Injury—TP53—psoriasis	3.86e-05	0.000531	CbGpPWpGaD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	3.83e-05	0.000527	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—CXCL8—psoriasis	3.8e-05	0.000523	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—SOCS1—psoriasis	3.73e-05	0.000512	CbGpPWpGaD
Chloroquine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	3.57e-05	0.00049	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—CAT—psoriasis	3.55e-05	0.000488	CbGpPWpGaD
Chloroquine—TNF—Spinal Cord Injury—IL6—psoriasis	3.53e-05	0.000486	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—NDUFA5—psoriasis	3.51e-05	0.000482	CbGpPWpGaD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	3.48e-05	0.000478	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—NDUFA5—psoriasis	3.31e-05	0.000455	CbGpPWpGaD
Chloroquine—TNF—Adipogenesis—IL6—psoriasis	3.27e-05	0.00045	CbGpPWpGaD
Chloroquine—TLR9—Immune System—TYK2—psoriasis	3.25e-05	0.000446	CbGpPWpGaD
Chloroquine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	3.23e-05	0.000444	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	3.13e-05	0.000431	CbGpPWpGaD
Chloroquine—TNF—Apoptosis—TP53—psoriasis	3.1e-05	0.000427	CbGpPWpGaD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—IL6—psoriasis	3.1e-05	0.000426	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.09e-05	0.000425	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—VEGFA—psoriasis	3.09e-05	0.000425	CbGpPWpGaD
Chloroquine—TLR9—Immune System—IFNG—psoriasis	3.04e-05	0.000418	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—NDUFA5—psoriasis	3.04e-05	0.000418	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—LEP—psoriasis	3.01e-05	0.000414	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—CYP2S1—psoriasis	2.98e-05	0.00041	CbGpPWpGaD
Chloroquine—TLR9—Immune System—CD4—psoriasis	2.94e-05	0.000404	CbGpPWpGaD
Chloroquine—TNF—MAPK Signaling Pathway—TP53—psoriasis	2.91e-05	0.0004	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.83e-05	0.000389	CbGpPWpGaD
Chloroquine—TNF—SIDS Susceptibility Pathways—IL6—psoriasis	2.83e-05	0.000389	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—CYP2S1—psoriasis	2.82e-05	0.000387	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—APOE—psoriasis	2.76e-05	0.000379	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—LEP—psoriasis	2.75e-05	0.000378	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—APOE—psoriasis	2.75e-05	0.000378	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—IL6—psoriasis	2.73e-05	0.000375	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—TNF—psoriasis	2.65e-05	0.000364	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—NDUFA5—psoriasis	2.65e-05	0.000364	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.63e-05	0.000362	CbGpPWpGaD
Chloroquine—TLR9—Immune System—JUN—psoriasis	2.63e-05	0.000361	CbGpPWpGaD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	2.63e-05	0.000361	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—PPARG—psoriasis	2.62e-05	0.000361	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—CYP2S1—psoriasis	2.58e-05	0.000355	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—NFKBIA—psoriasis	2.56e-05	0.000352	CbGpPWpGaD
Chloroquine—TLR9—Immune System—NFKB1—psoriasis	2.53e-05	0.000348	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—NDUFA5—psoriasis	2.49e-05	0.000343	CbGpPWpGaD
Chloroquine—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	2.46e-05	0.000338	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—PPARG—psoriasis	2.4e-05	0.00033	CbGpPWpGaD
Chloroquine—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	2.35e-05	0.000322	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—TYK2—psoriasis	2.3e-05	0.000316	CbGpPWpGaD
Chloroquine—TLR9—Immune System—STAT3—psoriasis	2.27e-05	0.000313	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—CYP2S1—psoriasis	2.25e-05	0.000309	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—CYP2S1—psoriasis	2.12e-05	0.000291	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—TYK2—psoriasis	2.1e-05	0.000289	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CXCL8—psoriasis	1.83e-05	0.000251	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—NFKB1—psoriasis	1.79e-05	0.000246	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.74e-05	0.00024	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—JUN—psoriasis	1.7e-05	0.000234	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.68e-05	0.000231	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—NFKB1—psoriasis	1.64e-05	0.000225	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—NDUFA5—psoriasis	1.63e-05	0.000224	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—VEGFA—psoriasis	1.63e-05	0.000223	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—STAT3—psoriasis	1.61e-05	0.000221	CbGpPWpGaD
Chloroquine—TLR9—Immune System—IL6—psoriasis	1.59e-05	0.000218	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.52e-05	0.00021	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—VEGFA—psoriasis	1.48e-05	0.000204	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.48e-05	0.000203	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—STAT3—psoriasis	1.47e-05	0.000202	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—CARM1—psoriasis	1.46e-05	0.0002	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—CYP2S1—psoriasis	1.39e-05	0.000191	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—CARM1—psoriasis	1.38e-05	0.000189	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.35e-05	0.000186	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.31e-05	0.00018	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.29e-05	0.000177	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—CARM1—psoriasis	1.26e-05	0.000173	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.18e-05	0.000162	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.15e-05	0.000158	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—IL6—psoriasis	1.12e-05	0.000155	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—TP53—psoriasis	1.12e-05	0.000154	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—CARM1—psoriasis	1.1e-05	0.000151	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—CARM1—psoriasis	1.04e-05	0.000142	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—IL6—psoriasis	1.03e-05	0.000141	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—CAT—psoriasis	8.95e-06	0.000123	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—CAT—psoriasis	8.46e-06	0.000116	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—CAT—psoriasis	7.76e-06	0.000107	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—APOE—psoriasis	6.96e-06	9.57e-05	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—CARM1—psoriasis	6.77e-06	9.31e-05	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—CAT—psoriasis	6.76e-06	9.29e-05	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—APOE—psoriasis	6.57e-06	9.04e-05	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—CAT—psoriasis	6.37e-06	8.75e-05	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—PPARG—psoriasis	6.06e-06	8.33e-05	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—APOE—psoriasis	6.03e-06	8.29e-05	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—PPARG—psoriasis	5.73e-06	7.87e-05	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—APOE—psoriasis	5.25e-06	7.22e-05	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—PPARG—psoriasis	5.25e-06	7.22e-05	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—APOE—psoriasis	4.95e-06	6.8e-05	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—PPARG—psoriasis	4.57e-06	6.29e-05	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—PPARG—psoriasis	4.31e-06	5.93e-05	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—CAT—psoriasis	4.16e-06	5.72e-05	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—APOE—psoriasis	3.23e-06	4.45e-05	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—PPARG—psoriasis	2.82e-06	3.87e-05	CbGpPWpGaD
